These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

475 related items for PubMed ID: 15093889

  • 1. Short QT syndrome: pharmacological treatment.
    Gaita F, Giustetto C, Bianchi F, Schimpf R, Haissaguerre M, Calò L, Brugada R, Antzelevitch C, Borggrefe M, Wolpert C.
    J Am Coll Cardiol; 2004 Apr 21; 43(8):1494-9. PubMed ID: 15093889
    [Abstract] [Full Text] [Related]

  • 2. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P, Tegelkamp R, Osada N, Schimpf R, Wolpert C, Breithardt G, Borggrefe M, Eckardt L.
    J Cardiovasc Electrophysiol; 2007 Jun 21; 18(6):658-64. PubMed ID: 17521304
    [Abstract] [Full Text] [Related]

  • 3. Hydroquinidine therapy in Brugada syndrome.
    Hermida JS, Denjoy I, Clerc J, Extramiana F, Jarry G, Milliez P, Guicheney P, Di Fusco S, Rey JL, Cauchemez B, Leenhardt A.
    J Am Coll Cardiol; 2004 May 19; 43(10):1853-60. PubMed ID: 15145111
    [Abstract] [Full Text] [Related]

  • 4. Short QT Syndrome: a familial cause of sudden death.
    Gaita F, Giustetto C, Bianchi F, Wolpert C, Schimpf R, Riccardi R, Grossi S, Richiardi E, Borggrefe M.
    Circulation; 2003 Aug 26; 108(8):965-70. PubMed ID: 12925462
    [Abstract] [Full Text] [Related]

  • 5. Clinical characteristics and treatment of short QT syndrome.
    Wolpert C, Schimpf R, Veltmann C, Giustetto C, Gaita F, Borggrefe M.
    Expert Rev Cardiovasc Ther; 2005 Jul 26; 3(4):611-7. PubMed ID: 16076272
    [Abstract] [Full Text] [Related]

  • 6. Clinical and molecular genetics of the short QT syndrome.
    Schimpf R, Borggrefe M, Wolpert C.
    Curr Opin Cardiol; 2008 May 26; 23(3):192-8. PubMed ID: 18382206
    [Abstract] [Full Text] [Related]

  • 7. Quinidine in short QT syndrome: an old drug for a new disease.
    Kaufman ES.
    J Cardiovasc Electrophysiol; 2007 Jun 26; 18(6):665-6. PubMed ID: 17521305
    [No Abstract] [Full Text] [Related]

  • 8. Short QT syndrome: a review.
    Patel U, Pavri BB.
    Cardiol Rev; 2009 Jun 26; 17(6):300-3. PubMed ID: 19829181
    [Abstract] [Full Text] [Related]

  • 9. Electrophysiological effects of flecainide and sotalol in the human atrium during persistent atrial fibrillation.
    Kirchhof P, Engelen M, Franz MR, Ribbing M, Wasmer K, Breithardt G, Haverkamp W, Eckardt L.
    Basic Res Cardiol; 2005 Mar 26; 100(2):112-21. PubMed ID: 15696400
    [Abstract] [Full Text] [Related]

  • 10. Short QT syndrome. Genotype-phenotype correlations.
    Borggrefe M, Wolpert C, Antzelevitch C, Veltmann C, Giustetto C, Gaita F, Schimpf R.
    J Electrocardiol; 2005 Oct 26; 38(4 Suppl):75-80. PubMed ID: 16226079
    [Abstract] [Full Text] [Related]

  • 11. Short QT syndrome. Update on a recent entity.
    Maury P, Extramiana F, Sbragia P, Giustetto C, Schimpf R, Duparc A, Wolpert C, Denjoy I, Delay M, Borggrefe M, Gaita F.
    Arch Cardiovasc Dis; 2008 Oct 26; 101(11-12):779-86. PubMed ID: 19059573
    [Abstract] [Full Text] [Related]

  • 12. Use of a combination of class III and class Ic antiarrhythmic agents in patients with electrical storm.
    Fuchs T, Groysman R, Meilichov I.
    Pharmacotherapy; 2008 Jan 26; 28(1):14-9. PubMed ID: 18154469
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of quinidine in high-risk patients with Brugada syndrome.
    Belhassen B, Glick A, Viskin S.
    Circulation; 2004 Sep 28; 110(13):1731-7. PubMed ID: 15381640
    [Abstract] [Full Text] [Related]

  • 14. [Familial short QT syndrome].
    Lupoqlazoff JM, Denjoy I.
    Rev Prat; 2007 Jan 31; 57(2):121-5. PubMed ID: 17432514
    [Abstract] [Full Text] [Related]

  • 15. [Short QT Syndromes].
    Schulze-Bahr E.
    Herz; 2006 Apr 31; 31(2):118-22; quiz 142-3. PubMed ID: 16738834
    [Abstract] [Full Text] [Related]

  • 16. Effects of low-dose quinidine on ventricular tachyarrhythmias in patients with Brugada syndrome: low-dose quinidine therapy as an adjunctive treatment.
    Mizusawa Y, Sakurada H, Nishizaki M, Hiraoka M.
    J Cardiovasc Pharmacol; 2006 Mar 31; 47(3):359-64. PubMed ID: 16633076
    [Abstract] [Full Text] [Related]

  • 17. Drug-induced QT-interval prolongation: considerations for clinicians.
    Li EC, Esterly JS, Pohl S, Scott SD, McBride BF.
    Pharmacotherapy; 2010 Jul 31; 30(7):684-701. PubMed ID: 20575633
    [Abstract] [Full Text] [Related]

  • 18. Short QT syndrome: a predictable story.
    Brugada J, Gussak I, Brugada P.
    Cardiology; 2014 Jul 31; 128(3):231-3. PubMed ID: 24818800
    [No Abstract] [Full Text] [Related]

  • 19. Sudden arrhythmia death syndrome: importance of the long QT syndrome.
    Meyer JS, Mehdirad A, Salem BI, Kulikowska A, Kulikowski P.
    Am Fam Physician; 2003 Aug 01; 68(3):483-8. PubMed ID: 12924831
    [Abstract] [Full Text] [Related]

  • 20. In vivo effects of mutant HERG K+ channel inhibition by disopyramide in patients with a short QT-1 syndrome: a pilot study.
    Schimpf R, Veltmann C, Giustetto C, Gaita F, Borggrefe M, Wolpert C.
    J Cardiovasc Electrophysiol; 2007 Nov 01; 18(11):1157-60. PubMed ID: 17711440
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.